Volume Alert - GILD 101.13 Gilead Sciences $GILD H
Post# of 46527
Posted On: 11/17/2014 11:18:07 AM
Volume Alert - GILD 101.13 Gilead Sciences $GILD Hit a high today of 102.16 Closing the day 10:30 at 101.13 -0.93 -0.91% With a day low of 100.31 and a total volume of 4,690,330.
GILD Recent Posts: http://investorshangout.com/Gilead-Sciences-Inc-GILD-54232/
GILD Gilead Sciences Recent Headline News
Early Glance: Biotechnology companies
AP - 47 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 101.03 (-1.03), AMGN: 159.38 (+1.70), CELG: 105.03 (+0.98)
Stock Market News for November 17, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - 1 hr 6 mins ago
Benchmarks finished almost flat on Friday as Eurozone’s soft GDP data offset encouraging economic reports
DHI: 24.39 (+0.01), HAS: 56.37 (+2.35), BIIB: 306.66 (+1.23), VRTX: 112.01 (+0.67), HAL: 50.85 (-4.23), M: 61.75 (-0.30), WMT: 83.27 (+0.31), SLB: 95.97 (+0.65), COG: 33.55 (-0.07), GILD: 101.03 (-1.03), EOG: 96.66 (-1.50), ALXN: 189.14 (+0.38), MRO: 31.81 (-0.55), CSCO: 26.13 (-0.19), BHI: 66.99 (+7.10)
Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015
George Budwell, The Motley Fool - Motley Fool - Mon Nov 17, 7:13AM CST
As the healthcare sector rolls through its third-quarter earnings, a bucolic picture is coming into focus. Earnings across the sector are soaring due to new drug launches, a frenzy of acquisitions, and vast reorganizations that have helped to stem...
JNJ: 108.30 (+0.14), GILD: 101.02 (-1.04), ABBV: 65.21 (+1.21), CELG: 105.03 (+0.98)
3 Stocks the Smartest Investors Are Buying Right Now
Motley Fool Staff - Motley Fool - Mon Nov 17, 6:51AM CST
Stocks have soared to new heights over the last few years. Does this mean there are no longer any good buys out there? According to three of our contributing writers, that's not the case. 1. Broad-market exchange-traded funds ( John Maxfield )...
VOO: 187.26 (-0.07), GILD: 101.02 (-1.04), PFE: 29.96 (-0.38)
Intercept Pharmaceuticals Appoints Lisa Bright as Head of Europe
GlobeNewswire - Mon Nov 17, 5:01AM CST
Intercept Pharmaceuticals (Nasdaq:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver and intestinal diseases, announced today the appointment of Lisa Bright as Senior Vice President and Head of Europe, effective November 17, 2014. Ms. Bright will be a member of the Intercept senior management team and will spearhead Intercept's European operations based in London as the company prepares for the first indication approval and launch of obeticholic acid (OCA).
GILD: 101.02 (-1.04), ICPT: 157.37 (-5.21)
Studies: New Oral HCV Drug is Effective but Expensive; CBCD Reviews a Report
PRWeb - Sun Nov 16, 11:03PM CST
"Infected with the hepatitis C virus (HCV)? The CBCD recommends taking Novirin or Gene-Eden-VIR." - Greg Bennett, CBCD
GILD: 101.02 (-1.04)
'Fast Money' Recap: Was Friday the Start of a Bull Rally in Gold?
at The Street - Sat Nov 15, 4:00AM CST
The trading panel took a look at gold prices, which climbed 2.3% on Friday, as well as the potential for a pullback in biotech stocks.
AMZN: 320.41 (-7.41), TSRO: 30.43 (+0.81), XBI: 170.32 (+2.40), IBB: 291.50 (+3.33), CELG: 105.03 (+0.98), GILD: 101.02 (-1.04), GLD: 113.81 (-0.66), MCD: 95.82 (-0.39), SLV: 15.41 (-0.22), GDX: 19.02 (unch), TWTR: 40.96 (-0.89), AAPL: 114.28 (+0.10), BABA: 114.63 (-0.47)
Most active Nasdaq-traded stocks
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
GILD: 101.02 (-1.04), GERN: 3.04 (+0.28), ARCP: 8.71 (-0.02), MSFT: 49.30 (-0.28), AAPL: 114.28 (+0.10), CSCO: 26.12 (-0.20)
Final Glance: Biotechnology companies
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:
GILD: 101.02 (-1.04), AMGN: 159.38 (+1.70), CELG: 105.03 (+0.98)
Midday Glance: Biotechnology companies
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:
GILD: 101.02 (-1.04), AMGN: 159.38 (+1.70), CELG: 105.03 (+0.98)
Biotech off today led by Biogen
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 11:00AM CST
BIIB: 306.66 (+1.23), VRTX: 112.01 (+0.67), GILD: 101.02 (-1.04), ALXN: 189.14 (+0.38), AMGN: 159.38 (+1.70), IBB: 291.50 (+3.33), REGN: 407.17 (+11.97), CELG: 105.03 (+0.98)
Gilead Sciences (GILD) Crosses Pivot Point Support at $102.79
Comtex SmarTrend(R) - Fri Nov 14, 8:57AM CST
Shares of Gilead Sciences (NASDAQ:GILD) opened today below their pivot of $104.92 and have already reached the first level of support at $102.79. Investors may be interested in a cross of the next downside pivot targets of $101.38 and $97.84.
GILD: 101.02 (-1.04)
Regeneron Pharmaceuticals Offers More Upside Than Gilead Sciences
Alexander J. Poulos - Seeking Alpha - Fri Nov 14, 8:23AM CST
It is not often for one to come across such an explosive growth company such as Gilead Sciences (NASDAQ: GILD ). By virtue of its stronghold on the Hepatitis C market (HCV) combined with its dominant share in the HIV market, GILD has many...
GILD: 101.02 (-1.04), AMGN: 159.38 (+1.70), SNY: 47.32 (+0.64), REGN: 407.17 (+11.97)
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene
PR Newswire - Fri Nov 14, 8:10AM CST
Investor-Edge has initiated coverage on the following equities: Gilead Sciences Inc. (NASDAQ: GILD), MannKind Corporation (NASDAQ: MNKD), ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), iBio Inc. (NYSE MKT: IBIO), and Celgene Corporation (NASDAQ: CELG). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Thursday, November 13, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,652.79, up 0.23% and the NASDAQ Composite closed at 4,680.14, up 0.11%. The S&P 500 finished the session 0.05% higher at 2,039.33. During the trading session, four out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 783.78, down 0.10%, whereas the index has gained 10.85% in the previous three months. Register for your complimentary reports on these five stocks at:
GILD: 101.02 (-1.04), IBIO: 1.11 (+0.06), ARIA: 6.06 (-0.09), MNKD: 6.16 (unch), CELG: 105.05 (+1.00)
Reveal Earnings Forecast for BlackBerry, Twitter, Alibaba, Sirius XM, Gilead Sciences, and JD.Com
PR Newswire - Fri Nov 14, 7:45AM CST
EarningForecast.com has issued earnings forecast research with special focus on financial performance of the following stocks: BlackBerry (NASDAQ:BBRY), Twitter (NYSE:TWTR), Alibaba (NYSE:BABA), Sirius XM (NASDAQ:SIRI), Gilead Sciences (NASDAQ:GILD), and JD.Com (NASDAQ:JD).
GILD: 101.03 (-1.03), BBRY: 10.96 (-0.24), JD: 25.52 (-1.49), TWTR: 40.96 (-0.89), SIRI: 3.50 (-0.03), BABA: 114.64 (-0.46)
The Post AASLD Annual Meeting Hepatitis C Landscape
Leonard Yaffe - at Seeking Alpha - Fri Nov 14, 5:15AM CST
JNJ: 108.30 (+0.14), GILD: 101.03 (-1.03), MRK: 59.74 (+0.67), ABBV: 65.22 (+1.22)
If Gilead Has The Ace, Is AbbVie Holding The Big Joker?
Shock Exchange - at Seeking Alpha - Fri Nov 14, 1:55AM CST
GILD: 101.03 (-1.03), ABBV: 65.22 (+1.22)
GILD Recent Posts: http://investorshangout.com/Gilead-Sciences-Inc-GILD-54232/
GILD Gilead Sciences Recent Headline News
Early Glance: Biotechnology companies
AP - 47 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 101.03 (-1.03), AMGN: 159.38 (+1.70), CELG: 105.03 (+0.98)
Stock Market News for November 17, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - 1 hr 6 mins ago
Benchmarks finished almost flat on Friday as Eurozone’s soft GDP data offset encouraging economic reports
DHI: 24.39 (+0.01), HAS: 56.37 (+2.35), BIIB: 306.66 (+1.23), VRTX: 112.01 (+0.67), HAL: 50.85 (-4.23), M: 61.75 (-0.30), WMT: 83.27 (+0.31), SLB: 95.97 (+0.65), COG: 33.55 (-0.07), GILD: 101.03 (-1.03), EOG: 96.66 (-1.50), ALXN: 189.14 (+0.38), MRO: 31.81 (-0.55), CSCO: 26.13 (-0.19), BHI: 66.99 (+7.10)
Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015
George Budwell, The Motley Fool - Motley Fool - Mon Nov 17, 7:13AM CST
As the healthcare sector rolls through its third-quarter earnings, a bucolic picture is coming into focus. Earnings across the sector are soaring due to new drug launches, a frenzy of acquisitions, and vast reorganizations that have helped to stem...
JNJ: 108.30 (+0.14), GILD: 101.02 (-1.04), ABBV: 65.21 (+1.21), CELG: 105.03 (+0.98)
3 Stocks the Smartest Investors Are Buying Right Now
Motley Fool Staff - Motley Fool - Mon Nov 17, 6:51AM CST
Stocks have soared to new heights over the last few years. Does this mean there are no longer any good buys out there? According to three of our contributing writers, that's not the case. 1. Broad-market exchange-traded funds ( John Maxfield )...
VOO: 187.26 (-0.07), GILD: 101.02 (-1.04), PFE: 29.96 (-0.38)
Intercept Pharmaceuticals Appoints Lisa Bright as Head of Europe
GlobeNewswire - Mon Nov 17, 5:01AM CST
Intercept Pharmaceuticals (Nasdaq:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver and intestinal diseases, announced today the appointment of Lisa Bright as Senior Vice President and Head of Europe, effective November 17, 2014. Ms. Bright will be a member of the Intercept senior management team and will spearhead Intercept's European operations based in London as the company prepares for the first indication approval and launch of obeticholic acid (OCA).
GILD: 101.02 (-1.04), ICPT: 157.37 (-5.21)
Studies: New Oral HCV Drug is Effective but Expensive; CBCD Reviews a Report
PRWeb - Sun Nov 16, 11:03PM CST
"Infected with the hepatitis C virus (HCV)? The CBCD recommends taking Novirin or Gene-Eden-VIR." - Greg Bennett, CBCD
GILD: 101.02 (-1.04)
'Fast Money' Recap: Was Friday the Start of a Bull Rally in Gold?
at The Street - Sat Nov 15, 4:00AM CST
The trading panel took a look at gold prices, which climbed 2.3% on Friday, as well as the potential for a pullback in biotech stocks.
AMZN: 320.41 (-7.41), TSRO: 30.43 (+0.81), XBI: 170.32 (+2.40), IBB: 291.50 (+3.33), CELG: 105.03 (+0.98), GILD: 101.02 (-1.04), GLD: 113.81 (-0.66), MCD: 95.82 (-0.39), SLV: 15.41 (-0.22), GDX: 19.02 (unch), TWTR: 40.96 (-0.89), AAPL: 114.28 (+0.10), BABA: 114.63 (-0.47)
Most active Nasdaq-traded stocks
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
GILD: 101.02 (-1.04), GERN: 3.04 (+0.28), ARCP: 8.71 (-0.02), MSFT: 49.30 (-0.28), AAPL: 114.28 (+0.10), CSCO: 26.12 (-0.20)
Final Glance: Biotechnology companies
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:
GILD: 101.02 (-1.04), AMGN: 159.38 (+1.70), CELG: 105.03 (+0.98)
Midday Glance: Biotechnology companies
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:
GILD: 101.02 (-1.04), AMGN: 159.38 (+1.70), CELG: 105.03 (+0.98)
Biotech off today led by Biogen
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 11:00AM CST
BIIB: 306.66 (+1.23), VRTX: 112.01 (+0.67), GILD: 101.02 (-1.04), ALXN: 189.14 (+0.38), AMGN: 159.38 (+1.70), IBB: 291.50 (+3.33), REGN: 407.17 (+11.97), CELG: 105.03 (+0.98)
Gilead Sciences (GILD) Crosses Pivot Point Support at $102.79
Comtex SmarTrend(R) - Fri Nov 14, 8:57AM CST
Shares of Gilead Sciences (NASDAQ:GILD) opened today below their pivot of $104.92 and have already reached the first level of support at $102.79. Investors may be interested in a cross of the next downside pivot targets of $101.38 and $97.84.
GILD: 101.02 (-1.04)
Regeneron Pharmaceuticals Offers More Upside Than Gilead Sciences
Alexander J. Poulos - Seeking Alpha - Fri Nov 14, 8:23AM CST
It is not often for one to come across such an explosive growth company such as Gilead Sciences (NASDAQ: GILD ). By virtue of its stronghold on the Hepatitis C market (HCV) combined with its dominant share in the HIV market, GILD has many...
GILD: 101.02 (-1.04), AMGN: 159.38 (+1.70), SNY: 47.32 (+0.64), REGN: 407.17 (+11.97)
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene
PR Newswire - Fri Nov 14, 8:10AM CST
Investor-Edge has initiated coverage on the following equities: Gilead Sciences Inc. (NASDAQ: GILD), MannKind Corporation (NASDAQ: MNKD), ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), iBio Inc. (NYSE MKT: IBIO), and Celgene Corporation (NASDAQ: CELG). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Thursday, November 13, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,652.79, up 0.23% and the NASDAQ Composite closed at 4,680.14, up 0.11%. The S&P 500 finished the session 0.05% higher at 2,039.33. During the trading session, four out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 783.78, down 0.10%, whereas the index has gained 10.85% in the previous three months. Register for your complimentary reports on these five stocks at:
GILD: 101.02 (-1.04), IBIO: 1.11 (+0.06), ARIA: 6.06 (-0.09), MNKD: 6.16 (unch), CELG: 105.05 (+1.00)
Reveal Earnings Forecast for BlackBerry, Twitter, Alibaba, Sirius XM, Gilead Sciences, and JD.Com
PR Newswire - Fri Nov 14, 7:45AM CST
EarningForecast.com has issued earnings forecast research with special focus on financial performance of the following stocks: BlackBerry (NASDAQ:BBRY), Twitter (NYSE:TWTR), Alibaba (NYSE:BABA), Sirius XM (NASDAQ:SIRI), Gilead Sciences (NASDAQ:GILD), and JD.Com (NASDAQ:JD).
GILD: 101.03 (-1.03), BBRY: 10.96 (-0.24), JD: 25.52 (-1.49), TWTR: 40.96 (-0.89), SIRI: 3.50 (-0.03), BABA: 114.64 (-0.46)
The Post AASLD Annual Meeting Hepatitis C Landscape
Leonard Yaffe - at Seeking Alpha - Fri Nov 14, 5:15AM CST
JNJ: 108.30 (+0.14), GILD: 101.03 (-1.03), MRK: 59.74 (+0.67), ABBV: 65.22 (+1.22)
If Gilead Has The Ace, Is AbbVie Holding The Big Joker?
Shock Exchange - at Seeking Alpha - Fri Nov 14, 1:55AM CST
GILD: 101.03 (-1.03), ABBV: 65.22 (+1.22)
(0)
(0)